Hershkovitz I, Speirs M, Katznelson A, Arensburg B, 1992. Unusual pathological condition in the lower extremities of a skeleton from ancient Israel. Am J Phys Anthropol 88: 23–26.
Kaufman MH, 2007. Sir George Ballingall (1786–1855): Regius Professor of Military Surgery in the University of Edinburgh. J Med Biogr 15: 75–81.
Ahmed AA, van de Sande WW, Fahal A, Bakker-Woudenberg I, Verbrugh H, van Belkum A, 2007. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 20: 146–151.
van de Sande WW, 2013. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis 7: e2550.
Ameen M, Arenas R, 2009. Developments in the management of mycetomas. Clin Exp Dermatol 34: 1–7.
Parker L, Singh D, Biz C, 2009. The dot-in-circle sign in Madura foot. J Foot Ankle Surg 48: 690.e1–5.
Mahgoub ES, 1976. Medical management of mycetoma. Bull World Health Organ 54: 303–310.
Fahal AH, Shaheen S, Jones DH, 2014. The orthopedic aspects of mycetoma. Bone Joint J 96-B: 420–425.
Garnica M, Nucci M, Queiroz-Telles F, 2009. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis. Curr Opin Infect Dis 22: 559–563.
Keating GM, 2005. Posaconazole. Drugs 65: 1553–1567, discussion 68–69.
Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A, 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47: 339–346.
Zoller E, Valente C, Baker K, Klepser ME, 2010. Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections. Drug Des Devel Ther 4: 299–311.
Jain V, Makwana GE, Bahri N, The MK, 2012. “Dot-in-Circle” sign on MRI in maduramycosis: a characteristic finding. J Clin Imaging Sci. 2: 66.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1177 | 896 | 51 |
Full Text Views | 429 | 12 | 0 |
PDF Downloads | 153 | 13 | 0 |
Madura foot is a chronic infection caused by fungus and/or bacteria. Traditionally, treatment has been surgical debridement or amputation. Non-invasive management with long-term antimicrobials alone has been reported as successful. We report a case of Madura foot in a Somali refugee successfully managed with oral posaconazole and ciprofloxacin.
Authors' addresses: Amit M. Sharma, Namita Sharma, Amritpal Nat, and Meghan Rane, SUNY Upstate Medical University, Medicine, Syracuse, NY, E-mails: SharmaA@upstate.edu, SharmaN@upstate.edu, NatAm@upstate.edu, and RaneM@upstate.edu. Timothy P. Endy, Upstate Medical University, Syracuse, NY, E-mail: endyt@upstate.edu.
Hershkovitz I, Speirs M, Katznelson A, Arensburg B, 1992. Unusual pathological condition in the lower extremities of a skeleton from ancient Israel. Am J Phys Anthropol 88: 23–26.
Kaufman MH, 2007. Sir George Ballingall (1786–1855): Regius Professor of Military Surgery in the University of Edinburgh. J Med Biogr 15: 75–81.
Ahmed AA, van de Sande WW, Fahal A, Bakker-Woudenberg I, Verbrugh H, van Belkum A, 2007. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 20: 146–151.
van de Sande WW, 2013. Global burden of human mycetoma: a systematic review and meta-analysis. PLoS Negl Trop Dis 7: e2550.
Ameen M, Arenas R, 2009. Developments in the management of mycetomas. Clin Exp Dermatol 34: 1–7.
Parker L, Singh D, Biz C, 2009. The dot-in-circle sign in Madura foot. J Foot Ankle Surg 48: 690.e1–5.
Mahgoub ES, 1976. Medical management of mycetoma. Bull World Health Organ 54: 303–310.
Fahal AH, Shaheen S, Jones DH, 2014. The orthopedic aspects of mycetoma. Bone Joint J 96-B: 420–425.
Garnica M, Nucci M, Queiroz-Telles F, 2009. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis. Curr Opin Infect Dis 22: 559–563.
Keating GM, 2005. Posaconazole. Drugs 65: 1553–1567, discussion 68–69.
Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A, 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47: 339–346.
Zoller E, Valente C, Baker K, Klepser ME, 2010. Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections. Drug Des Devel Ther 4: 299–311.
Jain V, Makwana GE, Bahri N, The MK, 2012. “Dot-in-Circle” sign on MRI in maduramycosis: a characteristic finding. J Clin Imaging Sci. 2: 66.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 1177 | 896 | 51 |
Full Text Views | 429 | 12 | 0 |
PDF Downloads | 153 | 13 | 0 |